(Q36018865)

11 August 2017

Preclinical monitoring of drug association in experimental chemotherapy of Chagas' disease by a new HPLC-UV method (English)

1 reference

11 August 2017

0 references

1 reference

Rodrigo Moreira da Silva

1

1 reference

11 August 2017

Líliam Teixeira Oliveira

2

1 reference

11 August 2017

Neila Márcia Silva Barcellos

3

1 reference

11 August 2017

Jacqueline de Souza

4

1 reference

11 August 2017

Marta de Lana

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

26 March 2012

1 reference

Antimicrobial Agents and Chemotherapy

11 August 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 August 2017

56

1 reference

11 August 2017

6

1 reference

11 August 2017

3344-3348

1 reference

Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Role of itraconazole metabolites in CYP3A4 inhibition

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Pharmacokinetic and pharmacodynamic issues in the treatment of parasitic infections

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Specific chemotherapy of Chagas disease: controversies and advances

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Nitroheterocyclic drugs with broad spectrum activity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Specific treatment of Chagas disease: current status and new developments

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Preclinical pharmacokinetics of benznidazole

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Drug-drug interactions by azole antifungals: Beyond a dogma of CYP3A4 enzyme activity inhibition

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Experimental Chagas' disease in dogs

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Single-dose pharmacokinetics of the trypanosomicide benznidazole in man

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Present situation and new strategies for Chagas disease chemotherapy: a proposal

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Pharmacokinetic interaction of ketoconazole and itraconazole with ciprofloxacin

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Molecular properties of WHO essential drugs and provisional biopharmaceutical classification

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

The dog as model for chemotherapy of the Chagas' disease.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370797

14 November 2018

Identifiers

DOI

10.1128/AAC.05785-11

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22450981

1 reference